Terpenoid-enriched Curcuma wenyujin nanovesicles for suppressing inflammation and restoring lipid homeostasis in MASH

Lin Liu , Jiale Niu , Yulong Sun , Zhuoyan He , Ziming Jiao , Guoen Li , Ganglin Wang , Fangjun Luo , Wei Li

Extracellular Vesicles and Circulating Nucleic Acids ›› 2026, Vol. 7 ›› Issue (2) : 1010 -28.

PDF
Extracellular Vesicles and Circulating Nucleic Acids ›› 2026, Vol. 7 ›› Issue (2) :1010 -28. DOI: 10.20517/evcna.2025.181
Original Article
Terpenoid-enriched Curcuma wenyujin nanovesicles for suppressing inflammation and restoring lipid homeostasis in MASH
Author information +
History +
PDF

Abstract

Aim: This study investigates the potential of Curcuma wenyujin-derived nanovesicles (CW-DNVs) to ameliorate metabolic dysfunction-associated steatohepatitis (MASH) and explores their underlying mechanism, focusing on hepatic macrophage accumulation and the regulation of lipid metabolism.

Methods: CW-DNVs were isolated via ultracentrifugation and sucrose gradient purification, and their physicochemical properties, cellular uptake, and in vivo biodistribution were characterized. Anti-inflammatory and lipid-lowering effects were evaluated in liver macrophages, hepatocytes, and a high-fat diet (HFD)-induced MASH mouse model. Lipidomic, small-molecule, and small RNA (sRNA) cargoes were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and RNA sequencing.

Results: CW-DNVs were spherical (~211 nm diameter), had a zeta potential of -27.4 mV, and were enriched in lipids, proteins, sRNAs, and terpenoids like well-known bioactive curcumenol and germacrone. Following intraperitoneal injection, they preferentially accumulated in Kupffer cells and were cleared within 7 days. In HFD-fed mice, CW-DNVs reduced body weight gain, hepatic steatosis, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglycerides (TG), total cholesterol (TC), and hepatic interleukin (IL)-6 levels. Mechanistically, they upregulated peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and microsomal triglyceride transfer protein (MTTP), and downregulated fatty acid synthase (FASN), promoting lipid oxidation and export. In vitro, CW-DNVs suppressed lipopolysaccharide-activated IL-6, IL-1β, and tumor necrosis factor-alpha (TNF-α) in macrophages and reduced oleic acid-induced lipid accumulation in hepatocytes. sRNA sequencing identified predominantly rRNA-derived fragments (not canonical miRNAs); however, anti-inflammatory activity was primarily attributed to terpenoid components.

Conclusion: CW-DNVs exert dual functionality in modulating macrophage inflammation and lipid metabolism. Loaded with bioactive terpenoids, they represent an effective natural nanoplatform for MASH therapy.

Keywords

Curcuma wenyujin / nanovesicles / terpenoid / inflammation / lipid homeostasis / MASH

Cite this article

Download citation ▾
Lin Liu, Jiale Niu, Yulong Sun, Zhuoyan He, Ziming Jiao, Guoen Li, Ganglin Wang, Fangjun Luo, Wei Li. Terpenoid-enriched Curcuma wenyujin nanovesicles for suppressing inflammation and restoring lipid homeostasis in MASH. Extracellular Vesicles and Circulating Nucleic Acids, 2026, 7 (2) : 1010-28 DOI:10.20517/evcna.2025.181

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Steinberg GR,Valvano CM,De Nardo W,Watt MJ. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms J Hepatol 2025 83 584 95

[2]

Park Y,Ko KS,Rhee BD. Non-alcoholic fatty liver disease (NAFLD) management in the community Int J Mol Sci 2025 26 2758 PMC11943420

[3]

Wang X,Zhang L,Dong B. Molecular mechanisms in MASLD/MASH-related HCC Hepatology 2025 82 1303 24 PMC11323288

[4]

Do A,Zahrawi F,Mehal WZ. Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH) Nat Rev Drug Discov 2025 24 171 89

[5]

Brisnovali NF,Haney C,Goedeke L. RezdiffraTM (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis Trends Pharmacol Sci 2024 45 1081 2 PMC11560534

[6]

Sanyal AJ,Newsome PN,Kliers I.et al. ; ESSENCE Study Group. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis N Engl J Med 2025 392 2089 99

[7]

Shah VN,Akturk HK,Kruger D.et al. Semaglutide in adults with type 1 diabetes and obesity NEJM Evid 2025 4 EVIDoa2500173

[8]

Jara M,Norlin J,Kjær MS.et al. Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis Nat Med 2025 31 3128 40 PMC12443624

[9]

Tilg H,Adolph TE,Dudek M,Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity Nat Metab 2021 3 1596 607

[10]

Safari Z,Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD) Cell Mol Life Sci 2019 76 1541 58 PMC11105223

[11]

Tran S,Baba I,Poupel L.et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis Immunity 2020 53 627 40.e5

[12]

Park SJ,Garcia Diaz J,Um E,Hahn YS. Major roles of kupffer cells and macrophages in NAFLD development Front Endocrinol 2023 14 1150118 PMC10235620

[13]

Zhao B,Lin H,Jiang X.et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery Theranostics 2024 14 4598 621 PMC11373634

[14]

Li Y,Wang Y,Zhao H,Pan Q,Chen G. Engineering strategies of plant-derived exosome-like nanovesicles: current knowledge and future perspectives Int J Nanomedicine 2024 19 12793 815 PMC11618857

[15]

Bai C,Liu J,Zhang X.et al. Research status and challenges of plant-derived exosome-like nanoparticles Biomed Pharmacother 2024 174 116543

[16]

Chen H,Ding Q,Li L.et al. Extracellular vesicle spherical nucleic acids JACS Au 2024 4 2381 92 PMC11200237

[17]

Cai Q,He B,Wang S.et al. Message in a bubble: shuttling small rnas and proteins between cells and interacting organisms using extracellular vesicles Annu Rev Plant Biol 2021 72 497 524 PMC8369896

[18]

Zeng Y,Yu S,Lu L,Zhang J,Xu C. Ginger-derived nanovesicles attenuate osteoarthritis progression by inhibiting oxidative stress via the Nrf2 pathway Nanomedicine 2024 19 2357 73 PMC11492688

[19]

Zhang M,Viennois E,Prasad M.et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer Biomaterials 2016 101 321 40 PMC4921206

[20]

Zhuang X,Deng ZB,Mu J.et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage J Extracell Vesicles 2015 4 28713 PMC4662062

[21]

Kumar A,Sundaram K,Teng Y.et al. Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance Theranostics 2022 12 1388 403 PMC8771553

[22]

Wang M,Chen J,Chen W.et al. Grape-derived exosome-like nanovesicles effectively ameliorate skin photoaging by protecting epithelial cells J Food Sci 2025 90 e70309

[23]

Jung D,Kim NE,Kim S.et al. Plant-derived nanovesicles and therapeutic application Pharmacol Ther 2025 269 108832

[24]

Di Gioia S,Hossain MN,Conese M. Biological properties and therapeutic effects of plant-derived nanovesicles Open Med 2020 15 1096 122 PMC7718644

[25]

Tiwari A,Soni N,Dongre S,Chaudhary M,Bissa B. The role of plant-derived extracellular vesicles in ameliorating chronic diseases Mol Biol Rep 2025 52 360

[26]

Xie H,Su D,Zhang J.et al. Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio J Ethnopharmacol 2020 246 111768

[27]

Wang L,Li X,Wang Y.et al. Rapid discrimination and screening of volatile markers for varietal recognition of Curcumae Radix using ATR-FTIR and HS-GC-MS combined with chemometrics J Ethnopharmacol 2021 280 114422

[28]

Dong J,Shao W,Yan P.et al. Curcumolide, a unique sesquiterpenoid with anti-inflammatory properties from Curcuma wenyujin Bioorg Med Chem Lett 2015 25 198 202

[29]

Li Y,Wu Y,Li Y,Guo F. Review of the traditional uses, phytochemistry, and pharmacology of Curcuma wenyujin Y. H. Chen et C. Ling J Ethnopharmacol 2021 269 113689

[30]

Brown GT,Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Metabolism 2016 65 1080 6 PMC4889547

[31]

Bond A,Morrissey MA. Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite J Cell Sci 2025 138 JCS263513 PMC11828473

[32]

Naeini MB,Bianconi V,Pirro M,Sahebkar A. The role of phosphatidylserine recognition receptors in multiple biological functions Cell Mol Biol Lett 2020 25 23 PMC7098104

[33]

Yan G,Xiao Q,Zhao J.et al. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy J Control Release 2024 367 425 40

[34]

Ding T,Li W,Li F,Ren M,Wang W. microRNAs: key regulators in plant responses to abiotic and biotic stresses via endogenous and Cross-Kingdom mechanisms Int J Mol Sci 2024 25 1154 PMC10816238

[35]

Luo Y,Zhu L,Ren Z.et al. Curcumae Rhizoma: an anti-cancer traditional Chinese medicine Chin Herb Med 2025 17 428 47 PMC12301925

[36]

Yin GP,Li LC,Zhang QZ.et al. iNOS inhibitory activity of sesquiterpenoids and a monoterpenoid from the rhizomes of Curcuma wenyujin J Nat Prod 2014 77 2161 9

[37]

Liu ZL,Zhao NN,Liu CM,Zhou L,Du SS. Identification of insecticidal constituents of the essential oil of Curcuma wenyujin rhizomes active against Liposcelis bostrychophila Badonnel Molecules 2012 17 12049 60 PMC6268378

[38]

Chu C,Yu L,Wu B.et al. A sequence of 28S rRNA-derived small RNAs is enriched in mature sperm and various somatic tissues and possibly associates with inflammation J Mol Cell Biol 2017 9 256 9

[39]

Gu X,Zhu D,Li Y.et al. Identification of plasma rRNA-derived small RNA biomarkers for diagnosis of colorectal cancer Mol Carcinog 2025 64 1580 90

[40]

Qiao D,Liu Y,Lei Y.et al. rRNA-derived small RNA rsRNA-28S regulates the chemoresistance of prostate cancer cells by targeting PTGIS Front Biosci 2023 28 102

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/